DISRUPTION OF EXPRESSION OF MRNA HSP27 AND UBIQUITIN AS A MECHANISM OF ESCAPING OF JURKAT LINE TUMOR CELLS FROM APOTOSIS

被引:0
|
作者
Nosareva, O. L. [1 ]
Stepovaya, Ye. A. [1 ]
Ryazantseva, N., V [1 ]
Zakirova, Ye., V [1 ]
Mazunin, I. O. [2 ]
Litvinova, L. S. [2 ]
Sokhonevich, N. A. [2 ]
Vesnina, O. N. [1 ]
Shakhristova, Ye., V [1 ]
机构
[1] Siberian State Med Univ, Tomsk, Russia
[2] Immanuel Kant Balt Fed Univ, Kaliningrad, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2015年 / 14卷 / 01期
关键词
Jukart tumor cells; apoptosis; ubiquitin; heat shock protein 27;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The research objective is to establish the link between heat shock protein 27 and ubiquitin mRNA expression as well as Jukart tumor cell apoptosis. The method of flow cytofluorometry has been used to evaluate apoptosis realization using FITC-labeled annexin V and propidium iodide along with the amount of reactive oxygen species. Spectrofluorimetry has been applied to register the caspase-3 activity. The content of hydroxyl radicals has been determined by spectrophotometry. The level of ubiquitin and heat shock protein 27 mRNA expression has been identified using real-time PCR. Intact Jukart tumor cells and blood lymphocytes of healthy donors served the material for the research. Following the carried out research it has been found out that the fall in the amount of annexin V positive cells and the reduced caspase-3 activity were accompanied by the rise in the content of hydroxyl radicals and reactive oxygen species against the backdrop of the increased heat shock protein 27 and ubiquitin mRNA expression in Jukart tumor cells.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 9 条
  • [1] Heat Shock Protein HSP27 and the Status of the Glutathione System in Dexamethasone-Induced Apoptosis of Jurkat Tumor Cells
    Nosareva, O. L.
    Stepovaya, E. A.
    Litvinova, L. S.
    Yurova, K. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 176 (05) : 617 - 619
  • [2] Study of Heat Shock Protein HSP90α,HSP70,HSP27 mRNA Expression in Human Acute Leukemia Cells
    肖侃艳
    刘文励
    屈伸
    孙汉英
    唐锦治
    同济医科大学学报(外文版), 1996, (04) : 212 - 216
  • [3] HSP27 DOES NOT PROTECT TUMOR-CELLS FROM CYTOTOXICITY MEDIATED BY TUMOR NECROSIS FACTORS BUT PROTECTS THESE CELLS FROM SUPRAOPTIMAL TEMPERATURES
    WISSING, D
    JAATTELA, M
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (04) : 645 - 645
  • [4] Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7
    Tsai, HF
    Lin, SJ
    Li, C
    Hsieh, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (04) : 1279 - 1286
  • [5] Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells:: possible involvement of the MT2 receptor
    Cabrera, J
    Quintana, J
    Reiter, RJ
    Loro, J
    Cabrera, F
    Estévez, F
    JOURNAL OF PINEAL RESEARCH, 2003, 35 (04) : 231 - 238
  • [6] Expression of HSP27 results in increased sensitivity to tumor necrosis factor, etoposide, and H2O2 in an oxidative stress-resistant cell line
    Mairesse, N
    Del Bino, G
    Horman, S
    Mosselmans, R
    Robaye, B
    Galand, P
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 177 (04) : 606 - 617
  • [7] Extract from mistletoe, Viscum album L., reduces Hsp27 and 14-3-3 protein expression and induces apoptosis in C6 rat glioma cells
    Ucar, E. O.
    Arda, N.
    Aitken, A.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (03): : 2801 - 2813
  • [8] Epidermal growth factor receptor mRNA expression in circulating tumor cells as a potential mechanism of molecular escape from regorafenib therapy.
    Matsusaka, Satoshi
    Ning, Yan
    Yang, Dongyun
    Zhang, Wu
    Hanna, Diana L.
    Cao, Shu
    Suenaga, Mitsukuni
    Okazaki, Satoshi
    Berger, Martin D.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Baseline circulating tumor cells (CTC) and serum heat shock protein 27 (Hsp27) levels are increased in advanced bladder cancer (BC) patients with poor prognostic factors: Results from the randomized phase 2 Borealis-1™ trial of first-line gemcitabine/cisplatin plus apatorsen or placebo
    Petrylak, D.
    Eigl, B.
    Senkus, E.
    Loriot, Y.
    Twardowski, P.
    Castellano, D.
    Blais, N.
    Sridhar, S.
    Sternberg, C.
    Retz, M.
    Blumenstein, B.
    Jacobs, C.
    Stewart, P.
    Bellmunt, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S525 - S525